
Knowles (KN) has drawn fresh attention after recent share price moves, with the stock up over the month and the past 3 months, prompting investors to reassess how its current valuation lines up with fundamentals.
See our latest analysis for Knowles.
The recent 1 day share price return of 1.37% comes after a weaker 7 day share price return of a 6.53% decline. However, the year to date share price return of 21.28% and 1 year total shareholder return of 64.63% point to momentum that has been building rather than fading.
If Knowles has caught your attention, it could be a good moment to widen the lens and look at 20 top founder-led companies as potential next ideas on your list.
With the share price near US$26.62 and an analyst target of US$28.50, plus an intrinsic value estimate that sits higher than today’s level, you have to ask: is Knowles still undervalued, or is the market already pricing in future growth?
Knowles' most followed narrative puts fair value at about $26.50, almost level with the last close of $26.62, and sets out a detailed earnings roadmap behind that figure.
The expansion of specialty film production and the launch of new product lines, such as inductors, are set to increase Knowles' total addressable market, providing incremental growth opportunities that should support revenue acceleration and potentially higher margins as these initiatives scale. Knowles' ongoing focus on delivering differentiated, custom-engineered solutions and scaling through operational efficiency is helping the company achieve higher factory utilization and margin improvement, positively impacting net margins and earnings.
Want to see what really sits behind that fair value? The narrative leans on firm earnings growth, improving profitability and a future valuation multiple that may surprise you.
Using an 8.68% discount rate, this narrative combines revenue expansion, wider profit margins and a lower future P/E to get to its $26.50 fair value estimate. It also assumes ongoing share repurchases and potential acquisition activity feed into earnings per share over time, which is very different from just looking at the current $50.9 million of net income in isolation.
Result: Fair Value of $26.50 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that story can change quickly if medtech and industrial demand softens, or if higher scrap costs and ramp inefficiencies keep squeezing margins for longer than expected.
Find out about the key risks to this Knowles narrative.
If this mix of optimism and concern feels familiar, do not sit on the sidelines. Review the full picture for yourself with 2 key rewards and 1 important warning sign.
If Knowles has sharpened your focus, do not stop here, use the Simply Wall St screener to quickly surface fresh companies that suit your style.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com